4582 — SymBio Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapSucker Stock

Annual balance sheet for SymBio Pharmaceuticals, fiscal year end - December 31st, JPY millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	Yuho	Yuho	Yuho	Yuho	Tanshin
Standards:	JAS	JAS	JAS	JAS	—
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	3,860	6,283	6,517	3,964	2,884
Net Total Accounts Receivable
Net Total Receivables	2,148	2,085	913	423	260
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	6,748	9,313	8,083	4,924	3,824
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	83.6	69	0	0	0
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	8,453	10,433	8,170	4,968	3,867
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	1,518	1,924	957	766	1,290
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Funded Status
Total Liabilities	1,707	1,927	960	771	2,595
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	6,746	8,506	7,210	4,198	1,272
Total Liabilities & Shareholders' Equity	8,453	10,433	8,170	4,968	3,867
Total Common Shares Outstanding